Imatinib Completed Phase 1 / 2 Trials for Alveolitis / Sclerosis, Progressive Systemic Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs